Welcome!

Microservices Expo Authors: Pat Romanski, Zakia Bouachraoui, Elizabeth White, Liz McMillan, Gopala Krishna Behara

News Feed Item

Certara Releases Version 7.0 of D360

Certara™, a leading provider of scientific software and consulting services to improve productivity and decision-making from drug discovery through clinical development, is pleased to announce the next major release of D360, version 7.0.

D360 is an integrated data query, analysis and visualization solution used by pharma and biotech companies to improve research productivity by providing unified access to diverse sources of scientific data integrated with analysis and collaboration tools. Based on customer requests, Certara has added several significant new features that provide alternative views of data, improve user workflow, and allow D360 to become a more integral part of a corporate informatics infrastructure:

  • All Entity Detail Reports show all known data for an entity of scientific interest such as drug compound or scientific study with a single click, regardless of the data source(s) where the information resides. All entity details reports are employed by users to quickly assess compound status and to locate scientific data of interest to apply to current projects.
  • Get Additional Data allows the addition of extra columns or rows of information to any dataset without re-running the entire query. This capability significantly enhances user workflow allowing rapid comparison with data records that may not be included in the original dataset and loading additional results that provide a better basis for scientific decisions.
  • Scheduled Queries lets users set up data searches to run automatically and regularly and access results in a variety of formats. Scheduled queries allow user to readily assess periodic changes in scientific data without the need to manually execute data queries.
  • Notifications improve the ability to share research findings with a project team by informing team members automatically of changes or updates in available information.
  • Web-service access to D360 functionality: execute and run queries remotely through a web-service and feed retrieved data into 3rd party applications. Web service access to D360 data functionality allows D360 to serve as a data provider to automated processes such as in silico model building and compound progression funnels.

Certara has successfully configured D360 to support translational science by federating cross-domain data and presenting it to the user in a unified view. For example, Certara has connected chemistry data with preclinical toxicology and PK data to explore relationships between drug safety and molecular structure. By tailoring the data ontology for each organization, users in discovery, pre-clinical and clinical drug development phases are able to use D360 to build their own queries without IT support.

“D360 experienced strong growth in 2012 by not losing a single competitive evaluation,” said Jim Hopkins, CEO of Certara. “Through close collaboration with our clients we have been able to develop a set of features that further advance D360 as the leader in the industry and we are now very pleased to provide these important enhancements to thousands of existing D360 users.”

“In 2013 we expect our ecosystem of partners and clients to expand further through several high-profile relationships that are developing in the first half of this year,” said James Hayden, SVP of Global Sales and Marketing. “We want to support our clients by developing partnerships to enable connectivity to commonly used data sources, such as chemical structure data, web-based scientific compound data and preclinical or clinical data. Our clients are finding high value in the intersection of internal data with third party data and we want to facilitate this increasing demand while keeping application maintenance effort far lower than any other solution.”

About Certara

Certara is dedicated to improving human health through a broad spectrum of software products and consulting services, from molecular discovery through clinical development, with special focus on supporting translational approaches to drug development. Certara was formed by uniting industry leaders Tripos, provider of innovative scientific software solutions and services enabling life science researchers to improve the efficiency of molecular discovery; Simcyp, a research-based company providing predictive pharmacokinetic and pharmacodynamics tools, workshops, and consultancy services; and Pharsight® Corporation, provider of software and scientific consulting services to improve productivity and decision-making in preclinical and clinical drug development. Each Certara family brand has a primary focus on a key phase within the drug discovery and development process; combined, they offer a unique set of capabilities for modeling, analysis, and simulation with scientific informatics that can enable the cross-disciplinary approaches necessary for translational science initiatives. For more information, visit www.certara.com.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Microservices Articles
The explosion of new web/cloud/IoT-based applications and the data they generate are transforming our world right before our eyes. In this rush to adopt these new technologies, organizations are often ignoring fundamental questions concerning who owns the data and failing to ask for permission to conduct invasive surveillance of their customers. Organizations that are not transparent about how their systems gather data telemetry without offering shared data ownership risk product rejection, regu...
Containers and Kubernetes allow for code portability across on-premise VMs, bare metal, or multiple cloud provider environments. Yet, despite this portability promise, developers may include configuration and application definitions that constrain or even eliminate application portability. In this session we'll describe best practices for "configuration as code" in a Kubernetes environment. We will demonstrate how a properly constructed containerized app can be deployed to both Amazon and Azure ...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm. In their Day 3 Keynote at 20th Cloud Expo, Chris Brown, a Solutions Marketing Manager at Nutanix, and Mark Lav...
The now mainstream platform changes stemming from the first Internet boom brought many changes but didn’t really change the basic relationship between servers and the applications running on them. In fact, that was sort of the point. In his session at 18th Cloud Expo, Gordon Haff, senior cloud strategy marketing and evangelism manager at Red Hat, will discuss how today’s workloads require a new model and a new platform for development and execution. The platform must handle a wide range of rec...
The Internet of Things is clearly many things: data collection and analytics, wearables, Smart Grids and Smart Cities, the Industrial Internet, and more. Cool platforms like Arduino, Raspberry Pi, Intel's Galileo and Edison, and a diverse world of sensors are making the IoT a great toy box for developers in all these areas. In this Power Panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists discussed what things are the most important, which will have the most profound e...
If your cloud deployment is on AWS with predictable workloads, Reserved Instances (RIs) can provide your business substantial savings compared to pay-as-you-go, on-demand services alone. Continuous monitoring of cloud usage and active management of Elastic Compute Cloud (EC2), Relational Database Service (RDS) and ElastiCache through RIs will optimize performance. Learn how you can purchase and apply the right Reserved Instances for optimum utilization and increased ROI.
TCP (Transmission Control Protocol) is a common and reliable transmission protocol on the Internet. TCP was introduced in the 70s by Stanford University for US Defense to establish connectivity between distributed systems to maintain a backup of defense information. At the time, TCP was introduced to communicate amongst a selected set of devices for a smaller dataset over shorter distances. As the Internet evolved, however, the number of applications and users, and the types of data accessed and...
Consumer-driven contracts are an essential part of a mature microservice testing portfolio enabling independent service deployments. In this presentation we'll provide an overview of the tools, patterns and pain points we've seen when implementing contract testing in large development organizations.
In his session at 19th Cloud Expo, Claude Remillard, Principal Program Manager in Developer Division at Microsoft, contrasted how his team used config as code and immutable patterns for continuous delivery of microservices and apps to the cloud. He showed how the immutable patterns helps developers do away with most of the complexity of config as code-enabling scenarios such as rollback, zero downtime upgrades with far greater simplicity. He also demoed building immutable pipelines in the cloud ...
You have great SaaS business app ideas. You want to turn your idea quickly into a functional and engaging proof of concept. You need to be able to modify it to meet customers' needs, and you need to deliver a complete and secure SaaS application. How could you achieve all the above and yet avoid unforeseen IT requirements that add unnecessary cost and complexity? You also want your app to be responsive in any device at any time. In his session at 19th Cloud Expo, Mark Allen, General Manager of...